Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A number of ring and chain substituted aminothiazole derivatives with strong anti-inflammatory activity were studied for their antiproteolytic and oxygen radical scavenging properties. Their interactions with the stable free radical 1,1-diphenyl-2-picrylhydrazyl was determined. Their inhibition of the soybean
12-lipoxygenase
and
beta-glucuronidase
enzymes was evaluated. They scavenged superoxide anion and inhibited proteolysis to a non appreciable extent, whereas no activity on
beta-glucuronidase
and lipoxygenase was found. Their reducing ability was found to be low. Good correlation was obtained between the anti-inflammatory activity and clog P (theoretically calculated lipophilicity) and between anti-inflammatory activity and proteolytic inhibition. RM values were also determined.
...
PMID:In vitro studies of some 2,4-disubstituted thiazolyl-aminoketones with anti-inflammatory activity. Correlation with lipophilicity and structural characteristics. 900 87
The effect of some new 1-[3-(aroylo)] and one 1-[3-[aryloxy)]-propyl aminothiazole on inflammation was investigated in the carrageenin-induced mouse paw edema (36-58% edema inhibition). In addition they exhibited significant analgesic activity (55-80.6%) in the writhing test. Their antioxidant activity in vitro using the stable free radical 1.1-diphenyl-2-picrylhydrazyl (DPPH), was determined. Antiproteolytic ability and
beta-glucuronidase
inhibition have been studied. The tested compounds did not inhibit soybean
12-lipoxygenase
. RM values, as an expression of lipophilicity, were determined.
...
PMID:Anti-inflammatory activity of some novel 1-[3-(aroylo)] and one 1-[3-(aryloxy)]-propyl aminothiazole in correlation with structure and lipophilicity. 912 83
Some modified novel thiazol-5yl-aminoketones were evaluated for their anti-inflammatory, analgesic and antiproteolytic activities. Their inhibitory activity on
12-lipoxygenase
(12-LO) and
beta-glucuronidase
in vitro was estimated. Their interaction with the stable free radical 1,1-diphenyl-2-picrylhydrazyl (DPPH) and their RM values were also determined. For two of them, the effect on zoxazolamine-induced paralysis after a prolonged treatment was determined. The duration of paralysis for the same compounds, (only one administration, one before zoxazolamine injection) was recorded too. The 2-amino substituted derivatives seem to be more potent in comparison with the 2-phenyl. The tested compounds were found to influence proteolysis but not the activities at
beta-glucuronidase
and 12-LO. Their interaction with DPPH was mild. Compound 2 seems to modify the activity of the hepatic drug metabolizing enzymes. In conclusion, their activity is related to certain structural characteristics.
...
PMID:Effect of 2,4-disubstituted thiazol-5yl-aminoketones on inflammation. In vitro and in vivo biological studies: a structure-activity approach. 926 90